Streetbeat News

Analyst Ratings

CVI

Goldman Sachs analyst Neil Mehta maintains a 'Sell' rating on CVR Energy (NYSE:CVI) and raises the price target from $25 to $28.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 11:59 am

AVBH

Stephens & Co. analyst Andrew Terrell maintains an Overweight rating on Avidbank Holdings (OTC:AVBH) and raises the price target from $19 to $23.

Portfolio Pulse from richadhand@benzinga.com

July 25, 2023 | 11:59 am

CMA

Goldman Sachs analyst Ryan Nash maintains a Neutral rating on Comerica (NYSE:CMA) and raises the price target from $47 to $54.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 11:58 am

FUN

Goldman Sachs analyst Lizzie Dove maintains a Buy rating on Cedar Fair (NYSE:FUN) but has lowered the price target from $50 to $43.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 11:57 am

LCTX

Cantor Fitzgerald analyst Kristen Kluska has reiterated an Overweight rating on Lineage Cell Therapeutics (AMEX:LCTX) and maintained a $6 price target.

Portfolio Pulse from richadhand@benzinga.com

July 25, 2023 | 11:56 am

ZVIA

Wells Fargo analyst Chris Carey has maintained an Equal-Weight rating on Zevia (NYSE:ZVIA) and lowered the price target from $4 to $3.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 11:55 am

VRCA

RBC Capital analyst Gregory Renza maintains an Outperform rating on Verrica Pharmaceuticals (NASDAQ:VRCA) and raises the price target from $11 to $14.

Portfolio Pulse from richadhand@benzinga.com

July 25, 2023 | 11:54 am

SIGI

RBC Capital analyst Mark Dwelle has reiterated a 'Sector Perform' rating on Selective Insurance Gr (NASDAQ:SIGI) and maintained a $100 price target.

Portfolio Pulse from richadhand@benzinga.com

July 25, 2023 | 11:53 am

PRU

RBC Capital analyst Mark Dwelle has reiterated a 'Sector Perform' rating on Prudential Financial (NYSE:PRU) and maintained a price target of $94.

Portfolio Pulse from richadhand@benzinga.com

July 25, 2023 | 11:53 am

NXGN

RBC Capital analyst Sean Dodge has reiterated a 'Sector Perform' rating on NextGen Healthcare (NASDAQ:NXGN) and maintained a price target of $17.

Portfolio Pulse from richadhand@benzinga.com

July 25, 2023 | 11:52 am